Applying Toponome Imaging System to Colon Cancer: A step forward in cancer proteomics,Used

Applying Toponome Imaging System to Colon Cancer: A step forward in cancer proteomics,Used

In Stock
SKU: DADAX3659180092
Brand: LAP Lambert Academic Publishing
Sale price$124.05 Regular price$177.21
Save $53.16
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

In this proof of principle study, automated fluorescence Toponome Imaging System (TIS) was applied to find protein network structures distinguishing cancer tissue from normal colon tissue, taken from the same patient. Cancer specimen and corresponding normal tissue were harvested at colectomy from a single patient and prepared for TIS using a battery of different antibodies, including a number of putative stem cell markers. Expression of multiple protein clusters was determined and Combinatorial Molecular Phenotypes (CMPs) were analysed, using specific imageanalysis tools. By subcellular visualization procedures it was found, that many cell surface membrane molecules were closely associated with cellcytoskeleton as unique CMPs in the normal part of colon, while the same molecules were disassembled in the cancerous part, suggesting dysfunctional cytoskeletonmembrane complexes. Glandular and Stromal cell signatures were found, but interestingly also found were few TIS signatures identifying a very restricted subset of cells, expressing several putative stem cell markers, all restricted to the cancerous tissue.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed